TrialAmerican heart journal2010

Design and rationale of the Reduction of Infarct Expansion and Ventricular Remodeling with Erythropoietin after Large Myocardial Infarction (REVEAL) trial.

Chiara Melloni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.